Hepatitis C virus seroconversion among young injection drug users: Relationships and risks

被引:263
作者
Hahn, JA
Page-Shafer, K
Lum, PJ
Bourgois, P
Stein, E
Evans, JL
Busch, MP
Tobler, LH
Phelps, B
Moss, AR
机构
[1] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[3] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Anthropol Hist & Social Med, San Francisco, CA 94143 USA
[5] Blood Ctr Pacific, San Francisco, CA USA
[6] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA
[7] Chiron Corp, Emeryville, CA 94608 USA
关键词
D O I
10.1086/345554
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The present study examined reasons for the high incidence of hepatitis C virus (HCV) infection among young injection drug users (IDUs). IDUs <30 years old who tested negative for HCV antibody were enrolled in a prospective cohort. Risk factors for seroconversion were examined using time-dependent regression analyses: 48 of 195 IDUs seroconverted to HCV, for an incidence rate of 25.1/100 person-years (95% confidence interval, 18.7-32.9/100 person-years). Independent risk factors included sharing needles with an HCV-infected sex partner (borderline statistical significance, P = .11) or a person who was not a sex partner, sharing nonsterile drug-preparation equipment, pooling money with another IDU to buy drugs, and exchanging sex for money. Ubiquitous behaviors among young IDUs, such as the forming of injecting or sexual partnerships and consequent sharing of needles and drug preparation equipment, are risk factors for HCV. Interventions to reduce HCV transmission must recognize the importance of relationships on injecting risk.
引用
收藏
页码:1558 / 1564
页数:7
相关论文
共 43 条
[31]   NAT of the United States and Canadian blood supply [J].
Stramer, SL ;
Caglioti, S ;
Strong, DM .
TRANSFUSION, 2000, 40 (10) :1165-1168
[32]  
Tabor Edward, 2000, Transfusion (Bethesda), V40, P1273, DOI 10.1046/j.1537-2995.2000.40101273.x
[33]  
Thorpe, 2000, Ann Epidemiol, V10, P472, DOI 10.1016/S1047-2797(00)00155-1
[34]   Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment [J].
Thorpe, LE ;
Ouellet, LJ ;
Hershow, R ;
Bailey, SL ;
Williams, IT ;
Williamson, J ;
Monterroso, ER ;
Garfein, RS .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 155 (07) :645-653
[35]   Hepatitis C virus infection: Prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999 [J].
Thorpe, LE ;
Ouellet, LJ ;
Levy, JR ;
Williams, IT ;
Monterroso, ER .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (06) :1588-1594
[36]   EVALUATION OF 3RD-GENERATION SCREENING AND CONFIRMATORY ASSAYS FOR HCV ANTIBODIES [J].
UYTTENDAELE, S ;
CLAEYS, H ;
MERTENS, W ;
VERHAERT, H ;
VERMYLEN, C .
VOX SANGUINIS, 1994, 66 (02) :122-129
[37]   Maximum impact of HIV prevention measures targeted at injecting drug users [J].
van Ameijden, EJC ;
Coutinho, RA .
AIDS, 1998, 12 (06) :625-633
[38]  
van Beek I, 1998, BMJ-BRIT MED J, V317, P433, DOI 10.1136/bmj.317.7156.433
[39]   A LONGITUDINAL-STUDY ON THE INCIDENCE AND TRANSMISSION PATTERNS OF HIV, HBV AND HCV INFECTION AMONG DRUG-USERS IN AMSTERDAM [J].
VANAMEIJDEN, EJC ;
VANDENHOEK, JAR ;
MIENTJES, GHC ;
COUTINHO, RA .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1993, 9 (03) :255-262
[40]  
VANBEEK I, 1994, GENITOURIN MED, V70, P321